Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transfer from Methadone to Buprenorphine using Patches
NCT00750217Phase 4Unknown
- Sponsor
- Psychiatrische Universitätsklinik Zürich
- Start
- Aug 2008
- Primary completion
- Feb 2009
- Modality
- Orthosteric Ligands, Inhalation Devices
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of v1003 in heroin use disorder (HUD), sponsored by Psychiatrische Universitätsklinik Zürich. Primary endpoint: Short Opiate Withdrawal Scale at 14 days. Status: unknown.
02
Drugs
v1003
03
Conditions
heroin use disorder (HUD)
Beyond the preview
Go deeper on NCT00750217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00750217.